IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells

Angela P. Bastidas-Coral, Jolanda M. A. Hogervorst, Tymour Forouzanfar, Cornelis J. Kleverlaan, Pieter Koolwijk, Jenneke Klein-Nulend, Astrid D. Bakker

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Fracture repair is characterized by cytokine production and hypoxia. To better predict cytokine modulation of mesenchymal stem cell (MSC)-aided bone healing, we investigated whether interleukin 4 (IL-4), IL-6, and their combination, affect osteogenic differentiation, vascular endothelial growth factor (VEGF) production, and/or mammalian target of rapamycin complex 1 (mTORC1) activation by MSCs under normoxia or hypoxia. Human adipose stem cells (hASCs) were cultured with IL-4, IL-6, or their combination for 3 days under normoxia (20% O 2) or hypoxia (1% O 2), followed by 11 days without cytokines under normoxia or hypoxia. Hypoxia did not alter IL-4 or IL-6-modulated gene or protein expression by hASCs. IL-4 alone decreased runt-related transcription factor 2 (RUNX2) and collagen type 1 (COL1) gene expression, alkaline phosphatase (ALP) activity, and VEGF protein production by hASCs under normoxia and hypoxia, and decreased mineralization of hASCs under hypoxia. In contrast, IL-6 increased mineralization of hASCs under normoxia, and enhanced RUNX2 gene expression under normoxia and hypoxia. Neither IL-4 nor IL-6 affected phosphorylation of the mTORC1 effector protein P70S6K. IL-4 combined with IL-6 diminished the inhibitory effect of IL-4 on ALP activity, bone nodule formation, and VEGF production, and decreased RUNX2 and COL1 expression, similar to IL-4 alone, under normoxia and hypoxia. In conclusion, IL-4 alone, but not in combination with IL-6, inhibits osteogenic differentiation and angiogenic stimulation potential of hASCs under normoxia and hypoxia, likely through pathways other than mTORC1. These results indicate that cytokines may differentially affect bone healing and regeneration when applied in isolation or in combination.
Original languageEnglish
Pages (from-to)20520-20532
JournalJournal of Cellular Physiology
Volume234
Issue number11
DOIs
Publication statusPublished - 2019

Cite this

Bastidas-Coral, A. P., Hogervorst, J. M. A., Forouzanfar, T., Kleverlaan, C. J., Koolwijk, P., Klein-Nulend, J., & Bakker, A. D. (2019). IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells. Journal of Cellular Physiology, 234(11), 20520-20532. https://doi.org/10.1002/jcp.28652
Bastidas-Coral, Angela P. ; Hogervorst, Jolanda M. A. ; Forouzanfar, Tymour ; Kleverlaan, Cornelis J. ; Koolwijk, Pieter ; Klein-Nulend, Jenneke ; Bakker, Astrid D. / IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells. In: Journal of Cellular Physiology. 2019 ; Vol. 234, No. 11. pp. 20520-20532.
@article{f2c677cd461b4ee08ae9a06f2e786e4e,
title = "IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells",
abstract = "Fracture repair is characterized by cytokine production and hypoxia. To better predict cytokine modulation of mesenchymal stem cell (MSC)-aided bone healing, we investigated whether interleukin 4 (IL-4), IL-6, and their combination, affect osteogenic differentiation, vascular endothelial growth factor (VEGF) production, and/or mammalian target of rapamycin complex 1 (mTORC1) activation by MSCs under normoxia or hypoxia. Human adipose stem cells (hASCs) were cultured with IL-4, IL-6, or their combination for 3 days under normoxia (20{\%} O 2) or hypoxia (1{\%} O 2), followed by 11 days without cytokines under normoxia or hypoxia. Hypoxia did not alter IL-4 or IL-6-modulated gene or protein expression by hASCs. IL-4 alone decreased runt-related transcription factor 2 (RUNX2) and collagen type 1 (COL1) gene expression, alkaline phosphatase (ALP) activity, and VEGF protein production by hASCs under normoxia and hypoxia, and decreased mineralization of hASCs under hypoxia. In contrast, IL-6 increased mineralization of hASCs under normoxia, and enhanced RUNX2 gene expression under normoxia and hypoxia. Neither IL-4 nor IL-6 affected phosphorylation of the mTORC1 effector protein P70S6K. IL-4 combined with IL-6 diminished the inhibitory effect of IL-4 on ALP activity, bone nodule formation, and VEGF production, and decreased RUNX2 and COL1 expression, similar to IL-4 alone, under normoxia and hypoxia. In conclusion, IL-4 alone, but not in combination with IL-6, inhibits osteogenic differentiation and angiogenic stimulation potential of hASCs under normoxia and hypoxia, likely through pathways other than mTORC1. These results indicate that cytokines may differentially affect bone healing and regeneration when applied in isolation or in combination.",
author = "Bastidas-Coral, {Angela P.} and Hogervorst, {Jolanda M. A.} and Tymour Forouzanfar and Kleverlaan, {Cornelis J.} and Pieter Koolwijk and Jenneke Klein-Nulend and Bakker, {Astrid D.}",
year = "2019",
doi = "10.1002/jcp.28652",
language = "English",
volume = "234",
pages = "20520--20532",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "11",

}

IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells. / Bastidas-Coral, Angela P.; Hogervorst, Jolanda M. A.; Forouzanfar, Tymour; Kleverlaan, Cornelis J.; Koolwijk, Pieter; Klein-Nulend, Jenneke; Bakker, Astrid D.

In: Journal of Cellular Physiology, Vol. 234, No. 11, 2019, p. 20520-20532.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells

AU - Bastidas-Coral, Angela P.

AU - Hogervorst, Jolanda M. A.

AU - Forouzanfar, Tymour

AU - Kleverlaan, Cornelis J.

AU - Koolwijk, Pieter

AU - Klein-Nulend, Jenneke

AU - Bakker, Astrid D.

PY - 2019

Y1 - 2019

N2 - Fracture repair is characterized by cytokine production and hypoxia. To better predict cytokine modulation of mesenchymal stem cell (MSC)-aided bone healing, we investigated whether interleukin 4 (IL-4), IL-6, and their combination, affect osteogenic differentiation, vascular endothelial growth factor (VEGF) production, and/or mammalian target of rapamycin complex 1 (mTORC1) activation by MSCs under normoxia or hypoxia. Human adipose stem cells (hASCs) were cultured with IL-4, IL-6, or their combination for 3 days under normoxia (20% O 2) or hypoxia (1% O 2), followed by 11 days without cytokines under normoxia or hypoxia. Hypoxia did not alter IL-4 or IL-6-modulated gene or protein expression by hASCs. IL-4 alone decreased runt-related transcription factor 2 (RUNX2) and collagen type 1 (COL1) gene expression, alkaline phosphatase (ALP) activity, and VEGF protein production by hASCs under normoxia and hypoxia, and decreased mineralization of hASCs under hypoxia. In contrast, IL-6 increased mineralization of hASCs under normoxia, and enhanced RUNX2 gene expression under normoxia and hypoxia. Neither IL-4 nor IL-6 affected phosphorylation of the mTORC1 effector protein P70S6K. IL-4 combined with IL-6 diminished the inhibitory effect of IL-4 on ALP activity, bone nodule formation, and VEGF production, and decreased RUNX2 and COL1 expression, similar to IL-4 alone, under normoxia and hypoxia. In conclusion, IL-4 alone, but not in combination with IL-6, inhibits osteogenic differentiation and angiogenic stimulation potential of hASCs under normoxia and hypoxia, likely through pathways other than mTORC1. These results indicate that cytokines may differentially affect bone healing and regeneration when applied in isolation or in combination.

AB - Fracture repair is characterized by cytokine production and hypoxia. To better predict cytokine modulation of mesenchymal stem cell (MSC)-aided bone healing, we investigated whether interleukin 4 (IL-4), IL-6, and their combination, affect osteogenic differentiation, vascular endothelial growth factor (VEGF) production, and/or mammalian target of rapamycin complex 1 (mTORC1) activation by MSCs under normoxia or hypoxia. Human adipose stem cells (hASCs) were cultured with IL-4, IL-6, or their combination for 3 days under normoxia (20% O 2) or hypoxia (1% O 2), followed by 11 days without cytokines under normoxia or hypoxia. Hypoxia did not alter IL-4 or IL-6-modulated gene or protein expression by hASCs. IL-4 alone decreased runt-related transcription factor 2 (RUNX2) and collagen type 1 (COL1) gene expression, alkaline phosphatase (ALP) activity, and VEGF protein production by hASCs under normoxia and hypoxia, and decreased mineralization of hASCs under hypoxia. In contrast, IL-6 increased mineralization of hASCs under normoxia, and enhanced RUNX2 gene expression under normoxia and hypoxia. Neither IL-4 nor IL-6 affected phosphorylation of the mTORC1 effector protein P70S6K. IL-4 combined with IL-6 diminished the inhibitory effect of IL-4 on ALP activity, bone nodule formation, and VEGF production, and decreased RUNX2 and COL1 expression, similar to IL-4 alone, under normoxia and hypoxia. In conclusion, IL-4 alone, but not in combination with IL-6, inhibits osteogenic differentiation and angiogenic stimulation potential of hASCs under normoxia and hypoxia, likely through pathways other than mTORC1. These results indicate that cytokines may differentially affect bone healing and regeneration when applied in isolation or in combination.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85069724314&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31016754

U2 - 10.1002/jcp.28652

DO - 10.1002/jcp.28652

M3 - Article

VL - 234

SP - 20520

EP - 20532

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 11

ER -